Assignee
SIRNAOMICS INC
US7 patents
Top patents by PatentIndex Score
US11058779B2Jul 13, 2021
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
SIRNAOMICS INC18 citations82
US11697813B2Jul 11, 2023
Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis
SIRNAOMICS INC2 citations71
USRE46873EMay 29, 2018
Multi-targeted RNAi therapeutics for scarless wound healing of skin
SIRNAOMICS INC5 citations71
US12006500B2Jun 11, 2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)
SIRNAOMICS INC2 citations67
US12378552B2Aug 5, 2025
Oligomeric compound for inhibiting expression of factor XI
SIRNAOMICS INC0 citations62
US12054714B2Aug 6, 2024
Peptide docking vehicle for targeted nucleic acid delivery
SIRNAOMICS INC1 citations61
US9868952B2Jan 16, 2018
Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza
SIRNAOMICS INC0 citations46